載入...
The development of CAR design for tumor CAR-T cell therapy
In recent years, the chimeric antigen receptor modified T cells (Chimeric antigen receptor T cells, CAR-T) immunotherapy has developed rapidly, which has been considered the most promising therapy. Efforts to enhance the efficacy of CAR-based anti-tumor therapy have been made, such as the improvemen...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5862632/ https://ncbi.nlm.nih.gov/pubmed/29568411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24179 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|